ACAM2000|vaccinia (smallpox)|75        |Acambis, Inc|ACA       |Inactive|Inactive|2010/05/28|
ACAM2000|vaccinia (smallpox)|75        |Emergent BioSolutions|MIP       |Active|Active|2022/06/10|
ACEL-IMUNE|DTaP|20        ||          |Inactive|Inactive|2010/09/01|
ACTHIB|Hib (PRP-T)|48        |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
ADACEL|Tdap|115       |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
Adenovirus types 4 and 7|Adenovirus types 4 and 7|143       |TEVA Pharmaceuticals USA |TVA       |Active|Active|2019/07/23|
Adenovirus types 4 and 7|Adenovirus types 4 and 7|143       |Barr Laboratories|BRR       |Inactive|Inactive|2019/07/30|
Afluria|Influenza, seasonal, injectable|141       |Seqirus|SEQ       |Active|Active|2016/09/26|
AFLURIA|Influenza, seasonal, injectable|141       |bioCSL|CSL       |Inactive|Inactive|2016/09/26|
Afluria quadrivalent preservative free|influenza, injectable, quadrivalent, preservative free|150       |Seqirus|SEQ       |Active|Active|2016/10/04|
Afluria quadrivalent, preservative free, pediatric|Influenza, injectable,quadrivalent, preservative free, pediatric|161       |Seqirus|SEQ       |Active|Active|2019/08/26|
Afluria, preservative free|Influenza, seasonal, injectable, preservative free|140       |Seqirus|SEQ       |Active|Active|2016/09/26|
Afluria, preservative free|Influenza, seasonal, injectable, preservative free|140       |bioCSL|CSL       |Inactive|Inactive|2016/09/26|
Afluria, quadrivalent|influenza, injectable, quadrivalent|158       |Seqirus|SEQ       |Active|Active|2016/10/04|
AGRIFLU|Influenza, seasonal, injectable, preservative free|140       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Inactive|2017/11/15|
AS03 adjuvant|AS03 Adjuvant|801       |GlaxoSmithKline|SKB       |Active|Inactive|2015/09/11|
AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)|COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL |210       |AstraZeneca|ASZ       |Active|Active|2021/07/13|
ATTENUVAX|measles|05        |Merck and Co., Inc.|MSD       |Active|Inactive|2015/04/28|
Bexsero|meningococcal B, OMV|163       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Active|2015/02/02|
Bexsero|meningococcal B, OMV|163       |GlaxoSmithKline|SKB       |Active|Active|2016/03/22|
BIAVAX II|rubella/mumps|38        ||          |Inactive|Inactive|2010/09/01|
BIOTHRAX|anthrax|24        |Emergent BioSolutions|MIP       |Active|Active|2013/08/09|
BOOSTRIX|Tdap|115       |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
CERTIVA|DTaP|20        ||          |Inactive|Inactive|2010/09/01|
CERVARIX|HPV, bivalent|118       |GlaxoSmithKline|SKB       |Active|Inactive|2016/11/22|
COMIRNATY|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose|208       |Pfizer, Inc|PFR       |Active|Active|2022/05/18|
COMIRNATY|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose|217       |Pfizer, Inc|PFR       |Active|Active|2022/05/18|
COMVAX|Hib-Hep B|51        |Merck and Co., Inc.|MSD       |Active|Inactive|2016/03/11|
Coronavac (Sinovac) COVID-19 Vaccine|COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)|511       |Sinovac |SNV       |Active|Active|2021/07/13|
COVAXIN (Bharat) COVID-19 Vaccine|COVID-19 IV Non-US Vaccine (COVAXIN)|502       |Bharat Biotech International Limited|BBI       |Active|Active|2021/11/09|
Covifenz|SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)|512       |Medicago, Inc|MDO       |Active|Active|2022/04/11|
DAPTACEL|DTaP, 5 pertussis antigens|106       |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
DECAVAC|Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed|113       |Sanofi Pasteur|PMC       |Active|Inactive|2017/10/27|
DENGVAXIA|dengue fever|56        |Sanofi Pasteur|PMC       |Active|Active|2019/09/04|
DRYVAX|vaccinia (smallpox)|75        ||          |Inactive|Inactive|2010/09/01|
DT(GENERIC)|DT (pediatric)|28        |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
ENGERIX B-PEDS|Hep B, adolescent or pediatric|08        |GlaxoSmithKline|SKB       |Active|Active|2013/08/09|
ENGERIX-B-ADULT|Hep B, adult|43        |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
ERVEBO (Ebola Zaire Vaccine, Live)|Ebola Zaire vaccine, live, recombinant, 1mL dose|204       |Merck and Co., Inc.|MSD       |Active|Active|2021/03/23|
Fluad|influenza, trivalent, adjuvanted|168       |Seqirus|SEQ       |Active|Active|2016/08/09|
Fluad|influenza, trivalent, adjuvanted|168       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Active|2016/08/09|
FLUAD Quadrivalent|Influenza vaccine, quadrivalent, adjuvanted|205       |Seqirus|SEQ       |Active|Active|2020/07/20|
FLUARIX|Influenza, seasonal, injectable, preservative free|140       |GlaxoSmithKline|SKB       |Active|Active|2010/09/27|
Fluarix, quadrivalent, preservative free|influenza, injectable, quadrivalent, preservative free|150       |GlaxoSmithKline|SKB       |Active|Active|2013/08/09|
Flublok|influenza, recombinant, injectable, preservative free|155       |Protein Sciences|PSC       |Inactive|Active|2013/05/28|
Flublok quadrivalent|influenza, recombinant, quadrivalent,injectable, preservative free|185       |Protein Sciences|PSC       |Inactive|Inactive|2019/05/02|
Flublok quadrivalent|influenza, recombinant, quadrivalent,injectable, preservative free|185       |Sanofi Pasteur|PMC       |Active|Active|2019/05/02|
Flucelvax|Influenza, injectable, MDCK, preservative free|153       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Inactive|2016/06/24|
flucelvax, quadrivalent, preservative free|Influenza, injectable, MDCK, preservative free, quadrivalent|171       |Seqirus|SEQ       |Active|Active|2016/06/16|
Flucelvax, quadrivalent, with preservative|Influenza, injectable, MDCK, quadrivalent, preservative|186       |Seqirus|SEQ       |Active|Active|2017/06/27|
FLULAVAL|Influenza, seasonal, injectable|141       |ID Biomedical|IDB       |Active|Active|2013/09/10|
Flulaval quadrivalent|influenza, injectable, quadrivalent|158       |ID Biomedical|IDB       |Active|Active|2013/09/10|
Flulaval, preservative free|Influenza, seasonal, injectable, preservative free|140       |ID Biomedical|IDB       |Active|Active|2017/06/05|
Flulaval, quadrivalent, preservative free|influenza, injectable, quadrivalent, preservative free|150       |ID Biomedical|IDB       |Active|Active|2014/10/21|
FLUMIST|influenza, live, intranasal|111       |MedImmune, Inc. (AstraZeneca)|MED       |Active|Inactive|2015/10/23|
Flumist quadrivalent|influenza, live, intranasal, quadrivalent|149       |MedImmune, Inc. (AstraZeneca)|MED       |Active|Active|2012/08/07|
FLUVIRIN|Influenza, seasonal, injectable|141       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Active|2010/09/27|
Fluvirin|Influenza, seasonal, injectable|141       |Seqirus|SEQ       |Active|Active|2017/06/12|
Fluvirin preservative free|Influenza, seasonal, injectable, preservative free|140       |Seqirus|SEQ       |Active|Active|2017/06/12|
FLUVIRIN-PRESERVATIVE FREE|Influenza, seasonal, injectable, preservative free|140       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Active|2013/08/09|
FLUZONE|Influenza, seasonal, injectable|141       |Sanofi Pasteur|PMC       |Active|Active|2010/09/27|
FLUZONE High-Dose Quadrivalent|influenza, high-dose, quadrivalent|197       |Sanofi Pasteur|PMC       |Active|Active|2020/01/29|
Fluzone Quad Intradermal|influenza, intradermal, quadrivalent, preservative free|166       |Sanofi Pasteur|PMC       |Active|Active|2014/12/15|
FLUZONE Quadrivalent Southern Hemisphere|influenza, Southern Hemisphere, preservative free|201       |Sanofi Pasteur|PMC       |Active|Active|2020/03/12|
FLUZONE Quadrivalent Southern Hemisphere|influenza, Southern Hemisphere, quadrivalent, with preservative|202       |Sanofi Pasteur|PMC       |Active|Active|2020/03/12|
FLUZONE Quadrivalent Southern Hemisphere, Pediatric|influenza, Southern Hemisphere, pediatric, preservative free|200       |Sanofi Pasteur|PMC       |Active|Active|2020/04/21|
Fluzone Quadrivalent, pediatric|Influenza, injectable,quadrivalent, preservative free, pediatric|161       |Sanofi Pasteur|PMC       |Active|Active|2014/07/23|
Fluzone, intradermal|influenza, seasonal, intradermal, preservative free|144       |Sanofi Pasteur|PMC       |Active|Active|2013/08/09|
Fluzone, Quadrivalent|influenza, injectable, quadrivalent|158       |Sanofi Pasteur|PMC       |Active|Active|2013/08/08|
Fluzone, quadrivalent, preservative free|influenza, injectable, quadrivalent, preservative free|150       |Sanofi Pasteur|PMC       |Active|Active|2014/10/21|
FLUZONE-HIGH DOSE|Influenza, high dose seasonal|135       |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
FLUZONE-PRESERVATIVE FREE|Influenza, seasonal, injectable, preservative free|140       |Sanofi Pasteur|PMC       |Active|Active|2013/08/09|
GARDASIL|HPV, quadrivalent|62        |Merck and Co., Inc.|MSD       |Active|Inactive|2010/05/28|
Gardasil 9|HPV9|165       |Merck and Co., Inc.|MSD       |Active|Active|2014/12/11|
HAVRIX-ADULT|Hep A, adult|52        |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
HAVRIX-PEDS|Hep A, ped/adol, 2 dose|83        |GlaxoSmithKline|SKB       |Active|Active|2013/08/09|
HEPLISAV-B|HepB-CpG|189       |Dynavax, Inc.|DVX       |Active|Active|2017/10/27|
HIBERIX|Hib (PRP-T)|48        |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
HIBTITER|Hib (HbOC)|47        ||          |Inactive|Inactive|2010/08/18|
Imovax|rabies, intramuscular injection|18        |Sanofi Pasteur|PMC       |Active|Inactive|2016/12/12|
IMOVAX|Rabies - IM Diploid cell culture|175       |Sanofi Pasteur|PMC       |Active|Active|2016/10/19|
IMOVAX ID|rabies, intradermal injection|40        |Sanofi Pasteur|PMC       |Active|Inactive|2016/11/22|
INFANRIX|DTaP|20        |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
Influenza A (H5N1) -2013|Influenza A monovalent (H5N1), ADJUVANTED-2013|160       |ID Biomedical|IDB       |Active|Active|2014/01/16|
Influenza A monovalent (H5N1), ADJUVANTED-2013|Influenza A monovalent (H5N1), ADJUVANTED-2013|160       |GlaxoSmithKline|SKB       |Active|Inactive|2015/08/27|
IPOL|IPV|10        |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
IXIARO|Japanese Encephalitis IM|134       |Intercell Biomedical|INT       |Inactive|Inactive|2016/07/19|
Ixiaro|Japanese Encephalitis IM|134       |Valneva|VAL       |Active|Active|2016/07/19|
IXIARO|Japanese Encephalitis IM|134       |Vetter Pharma Fertigung GmbH & Co. KG|VET       |Inactive|Active|2017/12/04|
Janssen (J&J) COVID-19 Vaccine|COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL|212       |Janssen|JSN       |Active|Active|2021/07/12|
JE-VAX|Japanese encephalitis SC|39        |The Research Foundation for Microbial Diseases of Osaka University (BIKEN)|JPN       |Inactive|Inactive|2015/04/29|
JYNNEOS|Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection|206       |Bavarian Nordic A/S|BN        |Active|Active|2022/05/20|
KINRIX|DTaP-IPV|130       |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
MENACTRA|meningococcal MCV4P|114       |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
MENHIBRIX|Meningococcal C/Y-HIB PRP|148       |GlaxoSmithKline|SKB       |Active|Inactive|2017/11/15|
MENOMUNE|meningococcal MPSV4|32        |Sanofi Pasteur|PMC       |Active|Inactive|2017/10/27|
MenQuadfi|meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate|203       |Sanofi Pasteur|PMC       |Active|Active|2020/05/27|
Menveo|Meningococcal MCV4O|136       |GlaxoSmithKline|SKB       |Active|Active|2016/03/22|
MENVEO|Meningococcal MCV4O|136       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Active|2016/03/22|
MERUVAX II|rubella|06        |Merck and Co., Inc.|MSD       |Active|Inactive|2015/04/28|
M-M-R II|MMR|03        |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose|221       |Moderna US, Inc.|MOD       |Active|Active|2021/07/13|
Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose|228       |Moderna US, Inc.|MOD       |Active|Active|2021/07/13|
Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose|229       |Moderna US, Inc.|MOD       |Active|Active|2021/07/13|
Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose|207       |Moderna US, Inc.|MOD       |Active|Active|2021/07/13|
Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose|227       |Moderna US, Inc.|MOD       |Active|Active|2021/07/13|
MUMPSVAX|mumps|07        ||          |Inactive|Inactive|2010/09/01|
MYCOBAX|BCG|19        ||          |Inactive|Inactive|2015/12/11|
Novavax COVID-19 Vaccine|COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL|211       |Novavax, Inc.|NVX       |Active|Active|2021/03/23|
Novel influenza-H1N1-09|Novel influenza-H1N1-09|127       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Inactive|2015/08/27|
Novel influenza-H1N1-09|Novel influenza-H1N1-09|127       |Sanofi Pasteur|PMC       |Active|Inactive|2015/08/27|
Novel influenza-H1N1-09|Novel influenza-H1N1-09|127       |bioCSL|CSL       |Inactive|Inactive|2015/08/27|
Novel Influenza-H1N1-09, nasal|Novel Influenza-H1N1-09, nasal|125       |MedImmune, Inc. (AstraZeneca)|MED       |Active|Inactive|2015/08/27|
Novel influenza-H1N1-09, preservative-free|Novel influenza-H1N1-09, preservative-free|126       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Inactive|2015/08/27|
Novel influenza-H1N1-09, preservative-free|Novel influenza-H1N1-09, preservative-free|126       |Sanofi Pasteur|PMC       |Active|Inactive|2015/08/27|
Novel influenza-H1N1-09, preservative-free|Novel influenza-H1N1-09, preservative-free|126       |bioCSL|CSL       |Inactive|Inactive|2015/08/27|
OMNIHIB|Hib (PRP-T)|48        ||          |Inactive|Inactive|2010/09/01|
ORIMUNE|OPV|02        ||          |Inactive|Inactive|2010/09/01|
PEDIARIX|DTaP-Hep B-IPV|110       |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
PEDVAXHIB|Hib (PRP-OMP)|49        |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
PENTACEL|DTaP-Hib-IPV|120       |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose|217       |Pfizer, Inc|PFR       |Active|Active|2021/09/10|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose|301       |Pfizer, Inc|PFR       |Active|Active|2021/09/10|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose|218       |Pfizer, Inc|PFR       |Active|Active|2021/09/10|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose|219       |Pfizer, Inc|PFR       |Active|Active|2021/09/10|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose|300       |Pfizer, Inc|PFR       |Active|Active|2021/09/10|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose|208       |Pfizer, Inc|PFR       |Active|Active|2021/09/10|
PNEUMOVAX 23|pneumococcal polysaccharide PPV23|33        |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
PREHEVBRIO Hepatitis B Vaccine (Recombinant)|HepB recombinant, 3-antigen, Al(OH)3|220       |VBI Vaccines, Inc|VBI       |Active|Active|2022/01/25|
PREVNAR 13|Pneumococcal conjugate PCV 13|133       |Wyeth|WAL       |Active|Inactive|2010/05/28|
PREVNAR 13|Pneumococcal conjugate PCV 13|133       |Pfizer, Inc|PFR       |Active|Active|2010/05/28|
PREVNAR 20|Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF|216       |Pfizer, Inc|PFR       |Active|Active|2021/08/18|
PREVNAR 7|pneumococcal conjugate PCV 7|100       |Wyeth|WAL       |Active|Inactive|2015/09/24|
PREVNAR 7|pneumococcal conjugate PCV 7|100       |Wyeth|WAL       |Active|Inactive|2015/09/24|
Priorix|MMR|03        |GlaxoSmithKline|SKB       |Active|Active|2022/06/15|
PROHIBIT|Hib (PRP-D)|46        ||          |Inactive|Inactive|2010/09/01|
PROQUAD|MMRV|94        |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
Quadracel|DTaP-IPV|130       |Sanofi Pasteur|PMC       |Active|Active|2015/03/26|
RABAVERT|Rabies - IM fibroblast culture|176       |Novartis Pharmaceutical Corporation|NOV       |Inactive|Inactive|2016/10/19|
RABAVERT|Rabies - IM fibroblast culture|176       |GlaxoSmithKline|SKB       |Active|Active|2016/10/19|
RabAvert|rabies, intramuscular injection|18        |Chiron Corporation|CHI       |Inactive|Inactive|2016/03/22|
RECOMBIVAX-ADULT|Hep B, adult|43        |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
RECOMBIVAX-DIALYSIS|Hep B, dialysis|44        |Merck and Co., Inc.|MSD       |Active|Active|2013/08/09|
RECOMBIVAX-PEDS|Hep B, adolescent or pediatric|08        |Merck and Co., Inc.|MSD       |Active|Active|2013/08/09|
ROTARIX|rotavirus, monovalent|119       |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
ROTATEQ|rotavirus, pentavalent|116       |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
Sanofi COVID-19 |COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL|225       |Sanofi Pasteur|PMC       |Active|Active|2022/03/10|
Sanofi COVID-19 |COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL|226       |Sanofi Pasteur|PMC       |Active|Active|2022/03/10|
SHINGRIX|zoster recombinant|187       |GlaxoSmithKline|SKB       |Active|Active|2017/10/27|
Sinopharm (BIBP) COVID-19 Vaccine|COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)|510       |Sinopharm-Biotech|SPH       |Active|Active|2021/07/13|
SPIKEVAX|COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose|207       |Moderna US, Inc.|MOD       |Active|Active|2022/05/18|
Stamaril|Yellow fever vaccine - alt|183       |Sanofi Pasteur|PMC       |Active|Active|2017/03/02|
Td, adsorbed|Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed|09        |Massachusetts Biologic Laboratories|MBL       |Active|Inactive|2019/05/21|
Td, adsorbed |Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed|09        |Grifols|GRF       |Active|Inactive|2019/05/21|
TDVAX|Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed|09        |Massachusetts Biologic Laboratories|MBL       |Active|Active|2019/05/21|
Tenivac|Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed|113       |Sanofi Pasteur|PMC       |Active|Active|2013/08/09|
TETANUS TOXOID (GENERIC)|tetanus toxoid, adsorbed|35        |Sanofi Pasteur|PMC       |Active|Inactive|2010/05/28|
TETRAMUNE|DTP-Hib|22        ||          |Inactive|Inactive|2010/09/01|
TICE BCG|BCG|19        |Merck and Co., Inc.|MSD       |Active|Active|2021/07/26|
TICOVAC|Tick-borne encephalitis, inactivated, PF, 0.5mL|224       |Pfizer, Inc|PFR       |Active|Active|2021/11/04|
TICOVAC|Tick-borne encephalitis, inactivated, PF, 0.25mL|223       |Pfizer, Inc|PFR       |Active|Active|2021/11/04|
TRIHIBIT|DTaP-Hib|50        |Sanofi Pasteur|PMC       |Active|Inactive|2017/03/21|
TRIPEDIA|DTaP|20        |Sanofi Pasteur|PMC       |Active|Inactive|2017/11/15|
Trumenba|meningococcal B, recombinant|162       |Pfizer, Inc|PFR       |Active|Active|2014/11/03|
TWINRIX|Hep A-Hep B|104       |GlaxoSmithKline|SKB       |Active|Active|2010/05/28|
TYPHIM VI|typhoid, ViCPs|101       |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
TYPHOID-AKD|typhoid, parenteral, AKD (U.S. military)|53        ||          |Inactive|Inactive|2013/08/09|
VAQTA-ADULT|Hep A, adult|52        |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
VAQTA-PEDS|Hep A, ped/adol, 2 dose|83        |Merck and Co., Inc.|MSD       |Active|Active|2013/08/09|
VARIVAX|varicella|21        |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
VAXCHORA|cholera, live attenuated|174       |Emergent Travel Health, Inc (Formerly PaxVax)|PAX       |Active|Active|2016/06/17|
VAXELIS|DTaP,IPV,Hib,HepB|146       |MSP Vaccine Company - (partnership Merck and Sanofi Pasteur)|MSP       |Active|Active|2021/07/21|
VAXNEUVANCE|Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF|215       |Merck and Co., Inc.|MSD       |Active|Active|2021/08/18|
Vivotif|typhoid, oral|25        |Emergent Travel Health, Inc (Formerly PaxVax)|PAX       |Active|Active|2021/07/23|
VIVOTIF BERNA|typhoid, oral|25        |Crucell|CRU       |Inactive|Inactive|2016/05/02|
YF-VAX|yellow fever|37        |Sanofi Pasteur|PMC       |Active|Active|2010/05/28|
ZOSTAVAX|zoster live|121       |Merck and Co., Inc.|MSD       |Active|Active|2010/05/28|
